Adrienn Szentes

Title: Adrienn Szentes: Innovator in Pharmaceutical Chemistry

Introduction

Adrienn Szentes is a notable inventor based in Porva, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on crystalline solvated forms of complex compounds. His research has implications for drug formulation and therapeutic applications.

Latest Patents

Adrienn Szentes holds 1 patent for his invention titled "Crystalline solvated forms of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyridazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea." This patent relates to the development of crystalline solvated forms of the compound, along with methods for their production, pharmaceutical compositions, and treatment methods involving their administration.

Career Highlights

Throughout his career, Adrienn Szentes has worked with prominent companies in the pharmaceutical industry. He has been associated with Richter Gedeon Nyrt. and Sumitomo Pharma Co., Ltd., where he has contributed to various research and development projects. His expertise in pharmaceutical formulations has been instrumental in advancing drug delivery systems.

Collaborations

Adrienn has collaborated with several professionals in his field, including Michael Thomas Brandl and Jennifer Nelson. These collaborations have fostered innovation and have led to advancements in pharmaceutical research.

Conclusion

Adrienn Szentes is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact drug development significantly. His innovative approaches to crystalline forms of compounds demonstrate his commitment to advancing healthcare solutions.